Hemorrhagic Microangiopathy clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Biomarkers of CASH
Sorry, not currently recruiting here
The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.
San Francisco, California and other locations